EXCRETION OF FOLIC ACID IN BILE.

B. Creamer,M. Shiner

DOI: https://doi.org/10.1016/S0140-6736(65)92648-6

IF: 202.731

1965-04-24

The Lancet

Abstract:

What problem does this paper attempt to address?

The story of Invar [Basice Metrology]

R. Davis

DOI: https://doi.org/10.1109/MIM.2017.8036694

2017-09-14

Abstract:Material properties are affected by temperature. This can be a major obstacle when, for instance, measuring precise lengths with a metal ruler. If the ruler was calibrated by one laboratory at a reference temperature— say 15°C—but then used at a different temperature in another laboratory, then the calibration certificate might include the value of the ruler's coefficient of thermal expansion, so that a correction could be made for the thermal expansion between the lower and higher temperatures. But what if the second “laboratory” was not a laboratory at all? What if it was an open field and the length to be measured was a 10 km geodesic baseline needed for surveying? This was a serious problem from the late 19th century to the late 20th century.
Regulation of Bile Acid Biosynthesis by Hepatocyte Nuclear Factor 4Α

Yusuke Inoue,Aiming Yu,Sun Hee Yim,Xiaochao Ma,Kristopher W. Krausz,Junko Inoue,Charlie Xiang,Michael J. Brownstein,Gösta Eggertsen,Ingemar Björkhem,Frank J. Gonzalez

DOI: https://doi.org/10.1194/jlr.m500430-jlr200

IF: 6.676

2006-01-01

Journal of Lipid Research

Abstract:Hepatocyte nuclear factor 4α (HNF4α) regulates many genes that are preferentially expressed in liver. Mice lacking hepatic expression of HNF4α (HNF4αΔL) exhibited markedly increased levels of serum bile acids (BAs) compared with HNF4α-floxed (HNF4αF/F) mice. The expression of genes involved in the hydroxylation and side chain β-oxidation of cholesterol, including oxysterol 7α-hydroxylase, sterol 12α-hydroxylase (CYP8B1), and sterol carrier protein x, was markedly decreased in HNF4αΔL mice. Cholesterol 7α-hydroxylase mRNA and protein were diminished only during the dark cycle in HNF4αΔL mice, whereas expression in the light cycle was not different between HNF4αΔL and HNF4αF/F mice. Because CYP8B1 expression was reduced in HNF4αΔL mice, it was studied in more detail. In agreement with the mRNA levels, CYP8B1 enzyme activity was absent in HNF4αΔL mice. An HNF4α binding site was found in the mouse Cyp8b1 promoter that was able to direct HNF4α-dependent transcription. Surprisingly, cholic acid-derived BAs, produced as a result of CYP8B1 activity, were still observed in the serum and gallbladder of these mice. These studies reveal that HNF4α plays a central role in BA homeostasis by regulation of genes involved in BA biosynthesis, including hydroxylation and side chain β-oxidation of cholesterol in vivo.
Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors

Melinda A. Engevik,Christina N. Morra,Daniel Röth,Kristen Engevik,Jennifer K. Spinler,Sridevi Devaraj,Sue E. Crawford,Mary K. Estes,Markus Kalkum,James Versalovic

DOI: https://doi.org/10.3389/fmicb.2019.02305

IF: 5.2

2019-10-09

Frontiers in Microbiology

Abstract:Microbial metabolites, including B complex vitamins contribute to diverse aspects of human health. Folate, or vitamin B9, refers to a broad category of biomolecules that include pterin, para-aminobenzoic acid (pABA), and glutamate subunits. Folates are required for DNA synthesis and epigenetic regulation. In addition to dietary nutrients, the gut microbiota has been recognized as a source of B complex vitamins, including folate. This study evaluated the predicted folate synthesis capabilities in the genomes of human commensal microbes identified in the Human Microbiome Project and folate production by representative strains of six human intestinal bacterial phyla. Bacterial folate synthesis genes were ubiquitous across 512 gastrointestinal reference genomes with 13% of the genomes containing all genes required for complete de novo folate synthesis. An additional 39% of the genomes had the genetic capacity to synthesize folates in the presence of pABA, an upstream intermediate that can be obtained through diet or from other intestinal microbes. Bacterial folate synthesis was assessed during exponential and stationary phase growth through the evaluation of expression of select folate synthesis genes, quantification of total folate production, and analysis of folate polyglutamylation. Increased expression of key folate synthesis genes was apparent in exponential phase, and increased folate polyglutamylation occurred during late stationary phase. Of the folate producers, we focused on the commensal Lactobacillus reuteri to examine host-microbe interactions in relation to folate and examined folate receptors in the physiologically relevant human enteroid model. RNAseq data revealed segment-specific folate receptor distribution. Treatment of human colonoid monolayers with conditioned media (CM) from wild-type L. reuteri did not influence the expression of key folate transporters proton-coupled folate transporter (PCFT) or reduced folate carrier (RFC). However, CM from L. reuteri containing a site-specific inactivation of the folC gene, which prevents the bacteria from synthesizing a polyglutamate tail on folate, significantly upregulated RFC expression. No effects were observed using L. reuteri with a site inactivation of folC2, which results in no folate production. This work sheds light on the contributions of microbial folate to overall folate status and mammalian host metabolism.

microbiology
Preservation of conjugated primary bile acids by oxygenation of the small intestinal microbiota in vitro

Jenni Firrman,Elliot S. Friedman,Aaron Hecht,William C. Strange,Adrienne B. Narrowe,Karley Mahalak,Gary D. Wu,LinShu Liu

DOI: https://doi.org/10.1128/mbio.00943-24

IF: 6.4

2024-06-12

mBio

Abstract:ABSTRACT Bile acids play a critical role in the emulsification of dietary lipids, a critical step in the primary function of the small intestine, which is the digestion and absorption of food. Primary bile acids delivered into the small intestine are conjugated to enhance functionality, in part, by increasing aqueous solubility and preventing passive diffusion of bile acids out of the gut lumen. Bile acid function can be disrupted by the gut microbiota via the deconjugation of primary bile acids by bile salt hydrolases (BSHs), leading to their conversion into secondary bile acids through the expression of bacterial bile acid-inducible genes, a process often observed in malabsorption due to small intestinal bacterial overgrowth. By modeling the small intestinal microbiota in vitro using human small intestinal ileostomy effluent as the inocula, we show here that the infusion of physiologically relevant levels of oxygen, normally found in the proximal small intestine, reduced deconjugation of primary bile acids, in part, through the expansion of bacterial taxa known to have a low abundance of BSHs. Further recapitulating the small intestinal bile acid composition of the small intestine, limited conversion of primary into secondary bile acids was observed. Remarkably, these effects were preserved among four separate communities, each inoculated with a different small intestinal microbiota, despite a high degree of taxonomic variability under both anoxic and aerobic conditions. In total, these results provide evidence for a previously unrecognized role that the oxygenated environment of the small intestine plays in the maintenance of normal digestive physiology. IMPORTANCE Conjugated primary bile acids are produced by the liver and exist at high concentrations in the proximal small intestine, where they are critical for proper digestion. Deconjugation of these bile acids with subsequent transformation via dehydroxylation into secondary bile acids is regulated by the colonic gut microbiota and reduces their digestive function. Using an in vitro platform modeling the small intestinal microbiota, we analyzed the ability of this community to transform primary bile acids and studied the effect of physiological levels of oxygen normally found in the proximal small intestine (5%) on this metabolic process. We found that oxygenation of the small intestinal microbiota inhibited the deconjugation of primary bile acids in vitro . These findings suggest that luminal oxygen levels normally found in the small intestine may maintain the optimal role of bile acids in the digestive process by regulating bile acid conversion by the gut microbiota.

microbiology
A metabolic pathway for bile acid dehydroxylation by the gut microbiome

Masanori Funabashi,Tyler L. Grove,Min Wang,Yug Varma,Molly E. McFadden,Laura C. Brown,Chunjun Guo,Steven Higginbottom,Steven C. Almo,Michael A. Fischbach

DOI: https://doi.org/10.1038/s41586-020-2396-4

IF: 64.8

2020-06-17

Nature

Abstract:The gut microbiota synthesize hundreds of molecules, many of which influence host physiology. Among the most abundant metabolites are the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA), which accumulate at concentrations of around 500 μM and are known to block the growth of Clostridium difficile<a href="/articles/s41586-020-2396-4#ref-CR1">1</a>, promote hepatocellular carcinoma<a href="/articles/s41586-020-2396-4#ref-CR2">2</a> and modulate host metabolism via the G-protein-coupled receptor TGR5 (ref. <a href="/articles/s41586-020-2396-4#ref-CR3">3</a>). More broadly, DCA, LCA and their derivatives are major components of the recirculating pool of bile acids<a href="/articles/s41586-020-2396-4#ref-CR4">4</a>; the size and composition of this pool are a target of therapies for primary biliary cholangitis and nonalcoholic steatohepatitis. Nonetheless, despite the clear impact of DCA and LCA on host physiology, an incomplete knowledge of their biosynthetic genes and a lack of genetic tools to enable modification of their native microbial producers limit our ability to modulate secondary bile acid levels in the host. Here we complete the pathway to DCA and LCA by assigning and characterizing enzymes for each of the steps in its reductive arm, revealing a strategy in which the A–B rings of the steroid core are transiently converted into an electron acceptor for two reductive steps carried out by Fe–S flavoenzymes. Using anaerobic in vitro reconstitution, we establish that a set of six enzymes is necessary and sufficient for the eight-step conversion of cholic acid to DCA. We then engineer the pathway into Clostridium sporogenes, conferring production of DCA and LCA on a nonproducing commensal and demonstrating that a microbiome-derived pathway can be expressed and controlled heterologously. These data establish a complete pathway to two central components of the bile acid pool.

multidisciplinary sciences
[Determination of fetal bile acids and related steroidal compounds and their profile in neonatal biological fluids]

M Tohma

DOI: https://doi.org/10.1248/yakushi1947.116.10_753

YAKUGAKU ZASSHI

Abstract:The unusual bile acids hydroxylated at 1 beta-, 2 beta-, 4 beta-, 6 alpha- and 19-positions of cholic and chenodeoxycholic acids have been found from the meconium, neonatal bile, blood and urine, and amniotic fluid and pregnant urine by GC-MS analysis. These hydroxylated bile acids and their conjugates were synthesized as their references from the corresponding usual bile acids as starting materials, and the simultaneous and high performance analytical methods were developed by GC-MS, HPLC and enzyme immunoassay. The above mentioned unusual bile acids were identified and determined in significant amounts of the total bile acids in the biological fluids from neonates and pregnant women, but not from normal adults. We, therefore, proposed that they should be called as "fetal bile acids". Application of the developed methods was performed for the studies on the dynamic profile of fetal bile acids in developing fetus and neonates, and the clinical diagnosis of the hepatobiliary diseases of infants and congenital bile acid biosynthetic disorders, Zellweger syndrome, celebrotendinus xanthomatosis, 3-oxo-delta 4-steroid 5 beta-reductase deficiency and congenital biliary atresia. Analyses of steroidal hormones, equine estrogens and 18-hydroxycortisol were also described.
Dynamics of the enterohepatic circulation of bile acids in healthy humans.

F. Stellaard,D. Lütjohann

DOI: https://doi.org/10.1152/ajpgi.00476.2020

2021-05-12

Abstract:Regulation of bile acid metabolism is normally discussed as the regulation of bile acid synthesis, which serves to compensate for intestinal loss in order to maintain a constant pool size. After a meal, bile acids start cycling in the enterohepatic circulation. Farnesoid X receptor-dependent ileal and hepatic processes lead to negative feedback inhibition of bile acid synthesis. When the intestinal bile acid flux decreases, the inhibition of synthesis is released. The degree of inhibition of synthesis and the mechanism and degree of activation are still unknown. Moreover, in humans, a biphasic diurnal expression pattern of bile acid synthesis has been documented, indicating maximal synthesis around 3 pm and 9 pm. Quantitative data on the hourly synthesis schedule as compensation for intestinal loss are lacking. In this review, we describe the classical view on bile acid metabolism and present alternative concepts that are based on the overlooked feature that bile acids transit through the enterohepatic circulation very rapidly. A daily profile of the cycling and total bile acid pool sizes and potential controlled and uncontrolled mechanisms for synthesis are predicted. It remains to be elucidated by which mechanism clock genes interact with the Farnesoid X receptor-controlled regulation of bile acid synthesis. This mechanism could become an attractive target to enhance bile acid synthesis at night, when cholesterol synthesis is high, thus lowering serum LDL-cholesterol.

Medicine
Bile Acid Physiology

Agostino Di Ciaula,Gabriella Garruti,Raquel Lunardi Baccetto,Emilio Molina-Molina,Leonilde Bonfrate,David Q-H Wang,Piero Portincasa

DOI: https://doi.org/10.5604/01.3001.0010.5493

Abstract:The primary bile acids (BAs) are synthetized from colesterol in the liver, conjugated to glycine or taurine to increase their solubility, secreted into bile, concentrated in the gallbladder during fasting, and expelled in the intestine in response to dietary fat, as well as bio-transformed in the colon to the secondary BAs by the gut microbiota, reabsorbed in the ileum and colon back to the liver, and minimally lost in the feces. BAs in the intestine not only regulate the digestion and absorption of cholesterol, triglycerides, and fat-soluble vitamins, but also play a key role as signaling molecules in modulating epithelial cell proliferation, gene expression, and lipid and glucose metabolism by activating farnesoid X receptor (FXR) and G-protein-coupled bile acid receptor-1 (GPBAR-1, also known as TGR5) in the liver, intestine, muscle and brown adipose tissue. Recent studies have revealed the metabolic pathways of FXR and GPBAR-1 involved in the biosynthesis and enterohepatic circulation of BAs and their functions as signaling molecules on lipid and glucose metabolism.
Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis

Kimberly Lapham,Jonathan Novak,Lisa D Marroquin,Rachel Swiss,Shuzhen Qin,Christopher J Strock,Renato Scialis,Michael D Aleo,Thomas Schroeter,Heather Eng,A David Rodrigues,Amit S Kalgutkar

DOI: https://doi.org/10.1021/acs.chemrestox.6b00262

2016-10-17

Abstract:Conjugated hyperbilirubinemia accompanied by cholestasis is a frequent side effect during chronic treatment with the antimicrobial agent fusidic acid. Previous studies from our laboratory, addressing mechanisms of musculoskeletal toxicity arising from coadministration of fusidic acid with statins, demonstrated the ability of fusidic acid to potently inhibit human organic anion transporting polypeptides OATP1B1 (IC50 = 1.6 μM) and OATP1B3 (IC50 = 2.5 μM), which are responsible for the uptake-limited clearance of statins as well as bilirubin glucuronide conjugates. In the present work, inhibitory effects of fusidic acid were characterized against additional human hepatobiliary transporters [Na+/taurocholate cotransporting polypeptide (NTCP), bile salt export pump (BSEP), and multidrug resistance-associated proteins MRP2 and MRP3] as well as uridine glucuronosyl transferase (UGT1A1), which mediate the disposition of bile acids and bilirubin (and its conjugated metabolites). Fusidic acid demonstrated concentration-dependent inhibition of human NTCP- and BSEP-mediated taurocholic acid transport with IC50 values of 44 and 3.8 μM, respectively. Inhibition of BSEP activity by fusidic acid was also consistent with the potent disruption of cellular biliary flux (AC50 = 11 μM) in the hepatocyte imaging assay technology assay, with minimal impact on other toxicity end points (e.g., cytotoxicity, mitochondrial membrane potential, reactive oxygen species generation, glutathione depletion, etc.). Fusidic acid also inhibited UGT1A1-catalyzed β-estradiol glucuronidation activity in human liver microsomes with an IC50 value of 16 μM. Fusidic acid did not demonstrate any significant inhibition of ATP-dependent LTC4 transport (IC50's > 300 μM) in human MRP2 or MRP3 vesicles. R values, which reflect maximal in vivo inhibition, were estimated from a static mathematical model by taking into consideration the IC50 values generated in the various in vitro assays and clinically efficacious unbound fusidic acid concentrations. The magnitudes of in vivo interaction (R values) resulting from the inhibition of OATP1B1, UGT1A1, NTCP, and BSEP transport were ∼1.9-2.6, 1.1-1.2, 1.0-1.1, and 1.4-1.7, respectively, which are indicative of some degree of inherent toxicity risk, particularly via inhibition of OATP and BSEP. Collectively, these observations indicate that inhibition of human BSEP by fusidic acid could affect bile acid homeostasis, resulting in cholestatic hepatotoxicity in the clinic. Lack of direct inhibitory effects on MRP2 transport by fusidic acid suggests that conjugated hyperbilirubinemia does not arise via interference in MRP2-mediated biliary disposition of bilirubin glucuronides. Instead, it is possible that elevation in the level of bilirubin conjugates in blood is mediated through inhibition of hepatic OATPs, which are responsible for their reuptake and/or downregulation of MRP2 transporter as a consequence of cholestatic injury.
Diversity of Bile Acids in the Fetus and Newborn Infant

Roger Lester,Jan St. Pyrek,J. M. Little,Eugene W. Adcock

DOI: https://doi.org/10.1002/j.1536-4801.1983.tb08510.x

2024-01-04

Journal of Pediatric Gastroenterology and Nutrition

Abstract:Summary The bile acids found in the fetus and newborn are more numerous and diverse than has generally been appreciated. The four conventional bile acids, cholic, chenodeoxycholic, deoxycholic, and lithocholic acids, are found. In addition, however, stereoisomers of the conventional bile acids, bile acids with functional groups at different positions or in greater number than found in conventional bile acids, and "short‐chain" and "long‐chain" bile acids are found. The site of origin, pathways of synthesis, metabolism, and excretory routes of these unconventional bile acids are largely unknown. Their effects on the function of the liver and other tissues have not yet been established. It is uncertain which of these compounds is peculiar to the fetus and newborn, and which will be found in normal or abnormal adults. This review is an early look at a field bound to advance rapidly in the next several years.

pediatrics,gastroenterology & hepatology,nutrition & dietetics
The Concept of Folic Acid in Health and Disease

Yulia Shulpekova,Vladimir Nechaev,Svetlana Kardasheva,Alla Sedova,Anastasia Kurbatova,Elena Bueverova,Arthur Kopylov,Kristina Malsagova,Jabulani Clement Dlamini,Vladimir Ivashkin

DOI: https://doi.org/10.3390/molecules26123731

IF: 4.6

2021-06-18

Molecules

Abstract:Folates have a pterine core structure and high metabolic activity due to their ability to accept electrons and react with O-, S-, N-, C-bounds. Folates play a role as cofactors in essential one-carbon pathways donating methyl-groups to choline phospholipids, creatine, epinephrine, DNA. Compounds similar to folates are ubiquitous and have been found in different animals, plants, and microorganisms. Folates enter the body from the diet and are also synthesized by intestinal bacteria with consequent adsorption from the colon. Three types of folate and antifolate cellular transporters have been found, differing in tissue localization, substrate affinity, type of transferring, and optimal pH for function. Laboratory criteria of folate deficiency are accepted by WHO. Severe folate deficiencies, manifesting in early life, are seen in hereditary folate malabsorption and cerebral folate deficiency. Acquired folate deficiency is quite common and is associated with poor diet and malabsorption, alcohol consumption, obesity, and kidney failure. Given the observational data that folates have a protective effect against neural tube defects, ischemic events, and cancer, food folic acid fortification was introduced in many countries. However, high physiological folate concentrations and folate overload may increase the risk of impaired brain development in embryogenesis and possess a growth advantage for precancerous altered cells.

chemistry, multidisciplinary,biochemistry & molecular biology
High-performance liquid chromatography of bile pigments: separation and characterization of the urobilinoids

R V Bull,C K Lim,C H Gray

DOI: https://doi.org/10.1016/s0021-9673(00)82090-7

1981-11-20

Abstract:The detailed analysis of faecal bile pigments by high-performance liquid chromatography is described. Non-aqueous reversed-phase systems with acetonitrile-dimethyl sulphoxide or acetonitrile-dimethyl sulphoxide-methanol as the mobile phase on C1, C8 or C18-bonded silica are used for the group separation of verdinoids, violinoids and urobilinoids. A silica column, with acetonitrile-water-tetraethylene-pentamine as mobile phase, separates the laevorotatory stercobilin (C33H46N4O6) and half-stercobilin (C33H44N4O6) from the optically inactive urobilin (C33H42N4O6). The diastereoisomers are resolved by converting the urobilinoids into their dimethyl esters before chromatography on a silica column with n-heptane-methyl acetate-methanol containing 1% of diethylamine as the solvent system.
Folic Acid Supplementation in Patients with Elevated Homocysteine Levels

Alan D. Kaye,George M. Jeha,Alex D. Pham,Mitchell C. Fuller,Zachary I. Lerner,Gerald T. Sibley,Elyse M. Cornett,Ivan Urits,Omar Viswanath,Christopher G. Kevil

DOI: https://doi.org/10.1007/s12325-020-01474-z

2020-08-26

Advances in Therapy

Abstract:Folic acid is the most important dietary determinant of homocysteine (Hcy). Hcy serves as a critical intermediate in methylation reactions. It is created from methionine and either converted back to methionine or transformed into cysteine. This process is aided through several enzymes and three vitamins, folic acid, B12, and B6. Daily supplementation with 0.5–5.0 mg of folic acid typically lowers plasma Hcy levels by approximately 25%. Hyperhomocysteinemia is a known risk factor for coronary artery disease. In this regard, elevated levels of Hcy have been found in a majority of patients with vascular disease.

pharmacology & pharmacy,medicine, research & experimental
Physiology and Physical Chemistry of Bile Acids

Maria Chiara di Gregorio,Jacopo Cautela,Luciano Galantini

DOI: https://doi.org/10.3390/ijms22041780

IF: 5.6

2021-02-10

International Journal of Molecular Sciences

Abstract:Bile acids (BAs) are facial amphiphiles synthesized in the body of all vertebrates. They undergo the enterohepatic circulation: they are produced in the liver, stored in the gallbladder, released in the intestine, taken into the bloodstream and lastly re-absorbed in the liver. During this pathway, BAs are modified in their molecular structure by the action of enzymes and bacteria. Such transformations allow them to acquire the chemical–physical properties needed for fulling several activities including metabolic regulation, antimicrobial functions and solubilization of lipids in digestion. The versatility of BAs in the physiological functions has inspired their use in many bio-applications, making them important tools for active molecule delivery, metabolic disease treatments and emulsification processes in food and drug industries. Moreover, moving over the borders of the biological field, BAs have been largely investigated as building blocks for the construction of supramolecular aggregates having peculiar structural, mechanical, chemical and optical properties. The review starts with a biological analysis of the BAs functions before progressively switching to a general overview of BAs in pharmacology and medicine applications. Lastly the focus moves to the BAs use in material science.
Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study

David Galloway,Ethan Mezoff,Wujuan Zhang,Melissa Byrd,Conrad Cole,Inmaculada Aban,Samuel Kocoshis,Kenneth Dr Setchell,James E Heubi

DOI: https://doi.org/10.1002/jpen.1316

Abstract:Background: We determined qualitative and quantitative serum unconjugated bile acid (SUBA) levels among children with history of intestinal failure (IF) and suspected small bowel bacterial overgrowth (SBBO). Methods: This was a single-center, case-control pilot study conducted at Cincinnati Children's Hospital Medical Center. Children with history of IF and suspected SBBO were enrolled as subjects. Age-matched children without IF or suspected SBBO served as controls. All participants underwent small bowel fluid sampling for microbial culture analysis. Additionally, serum fractionated and total bile acids were measured by liquid chromatography-mass spectrometry at enrollment and following treatment for SBBO. Results: SUBA concentrations were elevated in IF subjects (median 1.16 μM, range 0.43-10.65 μM) compared with controls (median 0.10 μM, range 0.05-0.18 μM, P = 0.001). Among SUBA, chenodeoxycholic acid (CDCA) was significantly elevated in subjects (median 0.8 μM, range 0-7.08 μM) compared with controls (median 0 μM, range 0-0.03 μM, P = 0.012). When controls were excluded from analysis, IF subjects with positive aspirates for SBBO demonstrated higher concentration of CDCA (median 7.36 μM, range 1.1-8.28 μM) compared with IF subjects with negative aspirates (median 0.18 μM, range 0-1.06 μM, P = 0.017). Treatment for SBBO did not alter SUBA concentration. Conclusions: SUBA concentrations are elevated in children with history of IF and presumed SBBO compared with non-IF controls. CDCA was more prevalent in IF subjects with positive aspirates for SBBO compared with IF subjects with negative aspirates. The determination of SUBA concentration may be a useful surrogate to small bowel fluid aspiration in the diagnosis of SBBO in children with history of IF.
Role of folic acid in regulating gut microbiota and short-chain fatty acids based on an in vitro fermentation model

Xiaogu Zheng,Chenlan Xia,Manman Liu,Hongchen Wu,Jiaqian Yan,Zihao Zhang,Yingjie Huang,Qing Gu,Ping Li

DOI: https://doi.org/10.1007/s00253-023-12825-5

IF: 5

2024-01-05

Applied Microbiology and Biotechnology

Abstract:Folic acid deficiency is common worldwide and is linked to an imbalance in gut microbiota. However, based on model animals used to study the utilization of folic acid by gut microbes, there are challenges of reproducibility and individual differences. In this study, an in vitro fecal slurry culture model of folic acid deficiency was established to investigate the effects of supplementation with 5-methyltetrahydrofolate (MTHF) and non-reduced folic acid (FA) on the modulation of gut microbiota. 16S rRNA sequencing results revealed that both FA (29.7%) and MTHF (27.9%) supplementation significantly reduced the relative abundance of Bacteroidetes compared with control case (34.3%). MTHF supplementation significantly improved the relative abundance of Firmicutes by 4.49%. Notably, compared with the control case, FA and MTHF supplementation promoted an increase in fecal levels of Lactobacillus , Bifidobacterium , and Pediococcus . Short-chain fatty acid (SCFA) analysis showed that folic acid supplementation decreased acetate levels and increased fermentative production of isobutyric acid. The in vitro fecal slurry culture model developed in this study can be utilized as a model of folic acid deficiency in humans to study the gut microbiota and demonstrate that exogenous folic acid affects the composition of the gut microbiota and the level of SCFAs.

biotechnology & applied microbiology
Study on Bile Excretion of Scutellarein

Qing-Ming Che,Ying Chen,Li-Yi Pan,Hong He

DOI: https://doi.org/10.3321/j.issn:1001-5302.2006.20.017

2006-01-01

Abstract:OBJECTIVE:A HPLC-ECD method was established to determine scutellarin in rat bile.METHOD:The analytical column was Prontosil C18 (4.6 mm x 250 mm, 5 microm), and the mobile phase was consisted of methanol, 50 mmol x L(-1) phosphate buffer (adjusted by phosphoric acid to pH 2. 6), and tetrahydrofuran (40: 60: 10) , the flow rate was 1.0 mL x min(-1); the potential electrode voltage was 100 mv.RESULT:Concentration profile of scutellarin in rat bile was shown in this paper after oral administration of scutellarein.CONCLUSION:Only scutellarin was detected in rat bile, while both of scutellarin and scutellarein were detected in rat plasma.
P369 Altered fecal bile acid composition in active Ulcerative Colitis

S Sommersberger,S Gunawan,T Elger,T Fererberger,J Loibl,M Huss,A Kandulski,S Krautbauer,M Mueller-Schilling,G Liebisch,C Buechler,H Tews

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0499

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background A consistent finding in inflammatory bowel disease (IBD) is an altered composition of fecal bile acids, with an increase in primary bile acids and a decrease in secondary bile acids. It is less clear, whether fecal bile acids could prove to be biomarkers for IBD diagnosis and disease activity. The study aimed to determine correlations between eighteen fecal bile acid species and IBD entity as well as disease severity. Methods Eighteen fecal bile acid species were quantified from stool samples of 62 IBD patients and 17 controls using LC-MS/MS and stable isotope dilution. Bile acid levels were normalized to the dry weight of the fecal homogenates. For calculations, normalized bile acid concentrations and ratios of individual bile acid species to total bile acid levels were used. The p-values were corrected for multiple comparisons. Results In accordance with previous data, we showed that patients with IBD had more primary and less secondary bile acids in their stool compared to healthy controls, with greater differences when comparing healthy controls with ulcerative colitis (UC) than with Crohn ́s disease (CD). In CD patients’ fecal calprotectin showed no correlations with any of the bile acids. In UC negative correlations between fecal calprotectin levels and two secondary bile acids, glycine conjugated lithocholic acid (GLCA) and hyodeoxycholic acid (HDCA), and thus total levels of secondary bile acids, existed. Comparing patients with low calprotectin levels (<50 μg/g) and patients with high calprotectin levels (>500 μg/g) in UC revealed that the latter group had lower GLCA and HDCA. Fecal bile acid levels of CD patients did not change with higher calprotectin. Moreover, serum C-reactive protein negatively correlated with the secondary bile acids HDCA, ursodeoxycholic acid, lithocholic acid, taurine conjugated lithocholic acid, deoxycholic acid and its taurine conjugated form in UC but not CD patients. Conclusion To distinguish between IBD subtypes, it may be helpful to note that impaired fecal bile acid homeostasis is specific to patients with active UC.

gastroenterology & hepatology
Superior dialytic removal of bilirubin and bile acids by free fatty acid displacement and its combination with albumin dialysis

Shi Yuanyuan,Huajun Tian,Yifeng Wang,Yue Shen,Qiuyu Zhu,Feng Ding

DOI: https://doi.org/10.1111/aor.14004

2021-01-01

Artificial Organs

Abstract:One of the cardinal features of any liver replacement therapy is the ability to remove accumulated metabolites. The removal of water-soluble substances by dialysis procedures is well established. However, an unsolved problem is the low dialyzability of lipophilic toxins. This study aimed to explore whether bilirubin and bile acids removal can be increased by free fatty acid (FFA) displacement and its combination with albumin dialysis. First, we found that the protein binding of both bilirubin and bile acids decreased significantly with increasing FFA concentrations when co-incubated directly. Then, in vitro dialysis showed that fatty acid mixtures ([linoleic acid] / [oleic acid] = 2) infusion pre-filter effectively increased the fractional removal of bilirubin and bile acids from 1.43 ± 0.07% and 2.50 ± 0.12%, to 10.04 ± 0.29% and 6.12 ± 0.07%, respectively, which were significantly higher than albumin-based hemodialysis (HD); in vivo dialysis showed that lipid emulsion administration resulted in higher reduction ratios and more total solute removals for bilirubin and bile acids after 4 h HD compared with control, which was also superior to albumin-based HD. Finally, the highest dialysis efficacy was always observed by their combination whether in vitro or in vivo. These findings highlight that FFA displacement-based HD could efficiently improve the dialytic removal of bilirubin and bile acids, whilst its dialysis efficacy might even be superior to albumin-based HD. The concept of their combination may open up new avenues and possibilities in the field of dialysis to further enhance lipophilic toxins removal in liver failure.

EXCRETION OF FOLIC ACID IN BILE.

The story of Invar [Basice Metrology]

Regulation of Bile Acid Biosynthesis by Hepatocyte Nuclear Factor 4Α

Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors

Preservation of conjugated primary bile acids by oxygenation of the small intestinal microbiota in vitro

A metabolic pathway for bile acid dehydroxylation by the gut microbiome

[Determination of fetal bile acids and related steroidal compounds and their profile in neonatal biological fluids]

Dynamics of the enterohepatic circulation of bile acids in healthy humans.

Bile Acid Physiology

Inhibition of Hepatobiliary Transport Activity by the Antibacterial Agent Fusidic Acid: Insights into Factors Contributing to Conjugated Hyperbilirubinemia/Cholestasis

Diversity of Bile Acids in the Fetus and Newborn Infant

The Concept of Folic Acid in Health and Disease

High-performance liquid chromatography of bile pigments: separation and characterization of the urobilinoids

Folic Acid Supplementation in Patients with Elevated Homocysteine Levels

Physiology and Physical Chemistry of Bile Acids

Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study

Role of folic acid in regulating gut microbiota and short-chain fatty acids based on an in vitro fermentation model

Study on Bile Excretion of Scutellarein

P369 Altered fecal bile acid composition in active Ulcerative Colitis

Superior dialytic removal of bilirubin and bile acids by free fatty acid displacement and its combination with albumin dialysis